{
    "Trade/Device Name(s)": [
        "EasyMax BT Self-Monitoring Blood Glucose System"
    ],
    "Submitter Information": "EPS Bio Technology Corp.",
    "510(k) Number": "K182057",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121207"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "July 30, 2018",
    "Summary Letter Received Date": "July 31, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "EasyMax BT meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technique"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Meter",
        "Test Strip",
        "System",
        "Accessory",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for EasyMax BT Self-Monitoring Blood Glucose System with Bluetooth dongle for glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, or forearm for diabetes monitoring at home by a single patient, not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}